Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: September 2011
No. of Pages: 113
Price: $ 3500

GlobalData, the industry analysis specialist, has released its new report, “Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Neuropathic Pain Therapeutics market. The report identifies the key trends shaping and driving the global Neuropathic Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Neuropathic Pain Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope

The report provides information on the key drivers and challenges of the Neuropathic Pain Therapeutics market. Its scope includes -

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Neuropathic Pain Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

• Analysis of the current and future competition in the seven key countries Neuropathic Pain Therapeutics market.

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Neuropathic Pain Therapeutics market.

• Analysis of key recent licensing and partnership agreements in Neuropathic Pain Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the global Neuropathic Pain Therapeutics market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Neuropathic Pain Therapeutics market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

• What’s the next big thing in the global Neuropathic Pain Therapeutics market landscape? - Identify, understand and capitalize.

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2018

Published: September 2011
No. of Pages: 93
Price: $ 3500

GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Infections- Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Cytomegalovirus (CMV) Infections market. The report identifies the key trends shaping and driving the global Cytomegalovirus (CMV) Infections market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cytomegalovirus (CMV) Infections sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research

Scope

The report provides information on the key drivers and challenges of the Cytomegalovirus (CMV) Infections market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Cytomegalovirus (CMV) Infections market revenues data from 2005 to 2009, forecast for eight years to 2018.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Cytomegalovirus (CMV) Infections market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Cytomegalovirus (CMV) Infections market.

- Analysis of key recent licensing and partnership agreements in Cytomegalovirus (CMV) Infections market

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 

- Develop business strategies by understanding the trends shaping and driving the global Cytomegalovirus (CMV) Infections market. 

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Cytomegalovirus (CMV) Infections market in future. 

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 

- Whats the next big thing in the global Cytomegalovirus (CMV) Infections market landscape? – Identify, understand and capitalize.

Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Published: September 2011
No. of Pages: 78
Price: $ 2000



GlobalData, the industry analysis specialist, has released its new report, “Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global ALL market. The report identifies the key trends shaping and driving the global ALL market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global ALL sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData estimates the major markets (the US, the UK, Italy, Spain, France, Germany and Japan) for acute lymphocytic leukemia (ALL) therapeutics was valued at $427.6m in 2010 and forecasts it to grow at a Compound Annual Growth Rate (CAGR) of 2.9% to reach $524.0m by 2017. This growth is primarily attributed to the expected launch of Phase III pipeline candidates Marqibo (vincristine sulfate liposomes injection), GRASPA (asparaginase loaded into erythrocytes), recombinant asparaginase (asparaginase) and Depocyt (liposomal cytarabine) during the forecast period. The moderate growth rate is primarily attributed to the patent expiry of Gleevec in 2015 in the US; 2016 in Europe, Clolar in 2015 in Europe and Arranon in 2017 in US; 2013 in Europe.

Browse All: Pharmaceuticals Market Research

Scope
The report provides information on the key drivers and challenges of the acute lymphocytic leukemia market. Its scope includes -
• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) ALL therapeutics market revenues data from 2005 to 2010, forecast for seven years to 2017.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes such as tyrosine kinase inhibitor, DNA polymerase inhibitor, histone deacetylase (HDAC) inhibitor, dihydrofolate reductase inhibitor and Eg5 Inhibitor.
• Analysis of the current and future competition in the seven key countries acute lymphocytic leukemia therapeutics market. Key market players covered are Talon Therapeutics, Inc., Pfizer Inc, Genzyme Corporation, Erytech Pharma and Micromet, Inc.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the ALL therapeutics market.
• Analysis of key recent licensing and partnership agreements in ALL therapeutics market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global ALL therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global acute lymphocytic leukemia market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global ALL therapeutics market landscape? - Identify, understand and capitalize.

Oman Gas Markets, 2011

Published: September 2011
No. of Pages: 83
Price: $ 2500



This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Oman. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in Oman. The report Oman Gas Markets, 2011 compares the investment environment in Oman with other countries in the region. The profiles of the major companies operating in the natural gas sector in Oman together with the latest news and deals are also included in the report.

Scope
• Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.
• Historical and forecast data and information for all the major gas fields, (Liquified Natural Gas) LNG Terminals and pipelines in Oman for the period 2000-2015.
• Operator and equity details for major natural gas assets in Oman.
• Key information relating to market regulations, key energy assets and the key companies operating in the Oman’s energy industry.
• Information on the top companies in the Oman including business description, strategic analysis, and financial information.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy
• Gain a strong understanding of the country’s energy market.
• Facilitate market analysis and forecasting of future industry trends.
• Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.
• Assess your competitor’s major natural gas assets and their performance.
• Analyze the latest news and financial deals in the gas sector of each country.
• Develop strategies based on the latest operational, financial, and regulatory events.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
• Identify and analyze the strengths and weaknesses of the leading companies in the country.

Visible Light Communication (VLC) - A Potential Solution to the Global Wireless Spectrum Shortage

Published: September 2011
No. of Pages: 77
Price: $ 3500



GBI Research’s new report, “Visible Light Communication (VLC) - A Potential Solution to the Global Wireless Spectrum Shortage”, provides the key information and analysis on Visible Light Communication technology and market. Visible Light Communication or VLC is a method by which Light Emitting Diodes (LEDs) are used to transmit data using visible light as a transmitting medium. With the increasing usage of data over mobile phones and other wireless devices, spectrum shortage appears to be a real problem for which VLC can be offered as a potential solution. This solution is explained in detail in the report.

VLC technology can be used in a number of applications or end user segments like wireless networking, intelligent traffic management systems, home networking system, powerline communication and underwater communication.

VLC technology based devices primarily use LEDs, Opto-couplers and Image Sensors as components and each one represents a unique industry that has tremendous growth potential due to the rise of a new technology. Visible Light Communication based products are primarily dependent on efficient and low cost LEDs for fast data transmission rates and this is an important factor in the faster launch of commercial VLC based devices. The report explains each component type accompanied with revenues and forecasts till 2015.

GBI Research estimates that globally, around $100 million is invested in the research of Visible Light Communication technology and even major companies are conducting trials on VLC for incorporating in future products. This report explains in detail about the various key players in both the pure research centers of institutes and the commercial companies globally.

Browse All: Semiconductor Market Research Reports

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
• In-depth explanation of the solution from Visible Light Communication for the potential problem of wireless spectrum shortage.
• Key VLC market segments such as PowerLine Communication, Underwater Communication, Visible Light ID system, Optical Communication, Ubiquitous Networking and Intelligent Traffic Management Systems have been covered.
• Market Size for different component types used in VLC based devices in terms of sales revenue. Forecast forward until 2015
• A Comparative Case Study between Visible Light Communication and Infrared Communication.
• VLC initiatives of various VLC technology research centers and key market players are explained in detail.
• Comprehensive profiles of key players such as LVX Systems, Intel Corporation, Nakagawa Laboratories, Intel Corporation, OMEGA, Visible Light Communication Consortium and so on have been provided.

Reasons to buy
• Exploit growth opportunities across various IC component types specific to Visible Light Communication industry.
• Information about the most recent product and technology developments in the Visible Light Communication market.
• What is the future demand potential of different end user applications in Visible Light Communication market– Identify, understand and capitalize.
• Develop business strategies by understanding the trends, research and developments that are driving the Visible Light Communication market across the globe.
• Understand the competitors operating in the VLC market from the company and institutes profiles.
• Have an in-depth and holistic understanding of Visible Light Communication in technical and commercial perspectives.

Critical Healthcare Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles

Published: September 2011
No. of Pages: 86
Price: $ 3500



GBI Research, the leading business intelligence provider, has released its latest research, “Critical Healthcare Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles”. The report provides in-depth analysis of drivers and barriers that impact the global critical health market. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. The report analyzes the markets for factor XIII concentrates, fibrinogen concentrates, albumins, antithrombins and prothrombin complex concentrates in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. This includes treatment usage patterns, average annual cost of therapy and market size forecast until 2017 for the key geographies as well as the leading therapeutic segments. The report also provides information on the R&D product pipeline and explores the competitive landscape, including major players in the critical healthcare market. Finally, the report includes analysis on mergers and acquisitions (M&As) in the critical healthcare market.


GBI Research indicates that the global critical healthcare market is still an untapped market, with small numbers of players contributing to a major proportion of the overall critical health market. The market grew at very sluggish growth rate in the historic period, possible due to the unavailability of many of the products in certain markets, especially in the US. GBI Research estimates that the overall critical healthcare market in 2010 was worth $1,130.7m, representing a Compound Annual Growth Rate (CAGR) of 5% between 2002 and 2010. The global critical healthcare market is expected to grow at a moderate rate of 2.8% between 2010 and 2017, and is expected to reach $1,372.4m in 2017. The increased availability and usage of PCC, albumin products and factor concentrates for the management of various bleeding complications, and high risk surgical settings such as trauma, PPH, cardiac surgery and liver diseases, will drive the market in future. Approvals and launches of new products such as Riastap, Corifact and Atryn, and the anticipated launch of recombinant products, will boost growth of the critical healthcare market in the forecast period.

Scope
The report covers -
• Data and analysis on the critical healthcare market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
• Annualized market data for the critical healthcare market that includes markets for factor XIII concentrate, fibrinogen concentrate, antithrombin, prothrombin complex concentrate and albumin from 2002 to 2010, with forecasts to 2017.
• Market data on the geographical landscape and therapeutic landscape, including market size, market share, cost of therapy, sales volume and treatment usage patterns such as disease population, diagnosis population and prescription population.
• Key drivers and restraints that have had a significant impact on the market.
• The competitive landscape of the global critical healthcare market, including top companies benchmarking. The key companies studied in this report are CSL, Octapharma, Baxter, Grifols and LFB.
• Key M&A activities that took place in 2010 and 2011 in the critical healthcare market.

Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
• Align your product portfolio to the markets with high growth potential.
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Devise a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

Published: September 2011
No. of Pages: 151
Price: $ 3500


GBI Research, the leading business intelligence provider, has released its latest research “Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth”. The report provides in-depth analysis of drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2017 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse All: Pharmaceuticals Market Research

Scope
The scope of this report includes -
• Annualized market data for the blood disorders market from 2002 to 2010, forecast forward to 2017.
• Analysis of the leading therapeutic segments, including anemia, thrombosis, neutropenia, hemophilia A, hemophilia B, hemophilia C, von Willebrand’s disease and Alexander disease.
• Analysis of the blood disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
• Market characterization of the blood disorders market, including market size, annual cost of treatment and treatment usage pattern.
• Key drivers and barriers that have a significant impact on the market.
• Coverage of pipeline molecules in various phases of drug development.
• Competitive benchmarking of leading companies. The key companies studied in this report are Amgen, Bristol-Myers Squibb, Sanofi-Aventis, Baxter and Centocor Ortho Biotech Inc.
• Key M&A activities, licensing agreements, that have taken place from 2004 to 2011 in the global blood disorders market.

Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

Published: September 2011
No. of Pages: 121
Price: $ 3500



GBI Research’s report, “Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysis of the, drivers and barriers that affect the global immunoglobulins market. The report analyzes the markets for immunoglobulins products in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Epidemiology, revenue, and annual cost of therapy are forecast until 2017 for the key geographies as well as seven key therapeutic segments. The report also provides profiles for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

Browse All: Pharmaceuticals Market Research
Scope
The scope of this report includes -
• Annualized market data for the immunoglobulins market from 2002 to 2010, and forecast to 2017.
• Analysis of the seven key therapeutic segments. These include PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura.
• Analysis of the immunoglobulins markets in the leading geographies of the world, which include the US, the top five countries in Europe and Japan.
• Market characterization of the immunoglobulins (PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura) market, including market size, revenue analysis by the top seven geographies, annual cost of therapy, and epidemiology.
• Key drivers and barriers that have a significant impact on the market.
• Coverage of the pipeline molecules in various phases of drug development.
• Competitive profiling of the leading companies. The key companies studied in this report are Baxter International Inc., Biotest, Bio Products Laboratory Ltd., CSL Behring LLC, Kedrion, LFB, Octapharma, Talecris, and Grifols.
• Key M&A activities and licensing agreements between 2004 and 2011 in the global immunoglobulins market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
• Develop key strategic initiatives by understanding the key focus areas of the leading companies.
• Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013

Published: September 2011
No. of Pages: 85
Price: $ 3500

GBI Research’s new report, “Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Chinese pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes -

• Overall pharma, biotech and outsourcing market structure.

• Market characterization, including market size

• CMO & CRO market size and growth

• Key drivers and barriers that have a significant impact on the market.

• Competitive benchmarking of leading companies.

• Key M&A activities and strategic partnership deals that have taken place in 2009

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.

• Device a more tailored country strategy through the understanding of key drivers and barriers of the country’s pharmaceutical market.

• Develop key strategic initiatives by understanding the key focus areas of leading companies.

• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs

Published: September 2011
No. of Pages: 168
Price: $ 3500


GBI Research has released its latest research “Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs”, which provides insights into effective innovative strategies adopted by the pharmaceutical and biotechnology industry. The report examines numerous case studies of various R&D strategies such as outsourcing, offshoring, internal reorganization, R&D restructuring, risk sharing, public-private partnerships and others.
In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by GBI Research’s team of experts.

Scope
The scope of this report includes -
• Strategies adopted by pharmaceutical and biotechnology industry participants to succeed in the highly competitive pharmaceutical market
• Analysis of challenges faced by industry participants in increasing R&D output
• Analysis of strategies that have been ineffective in the pharmaceutical industry and those that have failed to achieve objectives
• Analysis on the role of CROs in improving R&D efficiencies in the pharmaceutical industry
• Key M&A activities and licensing agreements that have been aimed at increasing R&D outcomes

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Understand the different types of strategies being adopted in the industry to increase R&D outcomes
• Build effective strategies to improve R&D efficiencies through comprehension of strategies that worked and those that didn’t work
• Analyze numerous case studies on various strategies adopted by the pharmaceutical industry to evaluate the best strategies
• Compare strategies adopted in-house to those adopted in-house to evaluate and forecast outcomes

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Published: September2011
No. of Pages: 82
Price: $ 3500




GBI Research has released its latest report, “Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance” that provides key data, information and analysis of the major trends and developments in post marketing clinical research. The report provides a comprehensive insight into key technological developments, new approaches towards risk mitigation. The report talks about the key regulations, drug classes that require REMS and case studies of drugs for which REMS is required. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope
The scope of the report includes -
• Key technological developments, new approaches and strategies to mitigiate drug safety risks
• Preclinical outsourcing market forecast, 2010-2017.
• Analysis of regulation in each of the top geographies in US, Europe and Japan
• Key drivers and barriers  that have a significant impact on the industry

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Evaluate the effectiveness of REMS against various classes of drugs that have a poor safety record
• Understand best practices through case studies of REMS application in the industry
• Develop effective strategies to maximize the advantages through the understanding of REMS

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

Published: September 2011
No. of Pages: 114
Price: $ 3500

GBI Research, the leading business intelligence provider, has released its latest research, “Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global coagulation disorders market. The report analyzes the markets for coagulation disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Market size, annual cost of therapy and treatment usage patterns are forecast until 2016 for the key geographies, as well as the leading therapeutic segments which includes hemophilia A, hemophilia B and von Willebrand Disease. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global coagulation disorders market. 

Scope

The scope of this report includes -

• Annualized market data for the coagulation disorders market from 2002 to 2010, forecast forward to 2017.

• Analysis of the leading therapeutic segments, including hemophilia A, hemophilia B, and von Willebrand’s disease (vWD).

• Analysis of the coagulation disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.

• Market characterization of the coagulation disorders market, including market size, annual cost of therapy and treatment usage patterns.

• Key drivers and barriers that have a significant impact on the market.

• Coverage of pipeline molecules in various phases of drug development.

• Competitive benchmarking of leading companies. The key companies studied in this report are Baxter International Inc, Bayer AG, Novo Nordisk A/S, Pfizer Inc and CSL Behring LLC.

• Key M&A activities and licensing agreements that have taken place between 2004 and 2010 in the global coagulation disorders market.

Browse All: Pharmaceuticals Market Research

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.

• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with higher efficiency and better safety.

• Develop strategic initiatives by understanding the key focus areas of leading companies.

• Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

PT PLN (Persero) - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 55
Price: $ 1000





The report PT PLN (Persero) - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Power Market Research

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Glow Energy Public Company Limited - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 28
Price: $ 1000





The report Glow Energy Public Company Limited - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Energy Market Research

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
• Note*: Some sections may be missing if data is unavailable for the company.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Biogas Power in the United Kingdom (UK), Market Outlook to 2020, 2011 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles

Published: August 2011
No. of Pages: 80
Price: $ 2500




Biogas Power in the United Kingdom (UK), Market Outlook to 2020, 2011 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information on the biogas power market. The report provides in depth analysis on global renewable power market and global biogas power market with forecasts up to 2020. The report analyzes the power market outlook in the UK (includes thermal conventional, hydro and other renewables) and provides forecasts up to 2020. The research details renewable power market outlook in the UK (includes wind, biopower and solar PV) and provides forecasts up to 2020. The report highlights installed capacity and power generation trends from 2001 to 2020 in the UK biogas power market. The research also showcases top active and upcoming plants in the country. A detailed coverage on renewable energy policy framework governing the market along with policies specific to biogas power development in the UK are provided in the report. The research analyzes investment trends in the biopower power market in the UK and some of the major deals pertaining to the market are dealt in detail. The report also provides elaborate company profiles of some of the major market participants.

The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
The scope of the report includes -
• Brief introduction and overview on global carbon emissions and global energy consumption.
• Historical data provided from 2001 to 2010 and forecasts until 2020.
• Overview on the overall renewable power market in the world, highlighting the fuel types – wind, solar PV, solar thermal, biogas and biomass.
• Detailed overview on the global biogas power market with capacity and generation forecasts to 2020.
• Power market scenario in the UK with capacity and generation forecasts to 2020, highlighting fuel types such as thermal conventional, hydro and other renewables.
• Renewable power market scenario in the UK with capacity and generation forecasts to 2020, highlighting fuel types such as wind, biomass and solar PV.
• The UK biogas power installed capacity and generation trends to 2020
• Major active and upcoming plants in the country.
• Deal volume and value analysis of the UK biopower market. Deals analyzed on the basis of M&A, Partnership, Asset Financing, Debt Offering, Equity Offering and PE/VC.
• Elaborate profiling of some of the major market participants.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to -
• Identify key growth and investment opportunities in the UK biogas power market.
• Position yourself to gain the maximum advantage of the market’s growth potential by developing strategies based on the latest operational and regulatory events.
• Understand and respond to your competitors’ business structure, strategy and prospects.
•Do deals with an understanding of the mergers and partnerships that have shaped the market.

Smart Grid Readiness in Power Utilities - Technology Installation Trends and Outlook to 2016

Published: August 2011
No. of Pages: 72
Price: $ 3500

GlobalData’s latest research, “Smart Grid Readiness in Power Utilities - Technology Installation Trends and Outlook to 2016” provides an insight into the status of deployment of various smart grid technologies by utilities across the globe. Smart grids are efficient power delivery systems that utilize digital communication and advanced power electronics to integrate renewable energy resources and reduce transmission and distribution loss. The global deployment of smart grid technologies is expected to grow at a significant rate during the next few years until 2016. The deployments during the period 2005-2010 were restricted to North America and parts of Europe. This leaves a wide scope for the growth of smart grid technology deployment in Asia-Pacific, where utilities are struggling to reduce the inefficiencies in the power grid. The report provides information related to the past deployment trend and outlook for four different categories of smart grid technologies; integrated communication technologies, sensing and measurement technologies, cabling technologies and consumer interface technologies. The report covers the smart grid technology deployment activities in key nations across the globe.

Browse All: Power Market Research Reports

Scope

• Key geographies including US, Canada, Germany, France, Spain, Italy, China, Australia, South Korea, Japan, Brazil and Mexico

• Deployment trend and outlook for integrated communication technologies in key countries

• Deployment trend and outlook for sensing and measurement technologies in key countries

• Deployment trend and outlook for cabling technologies in key countries

• Deployment trend and outlook for consumer interface technologies in key countries

Reasons to buy

• Facilitate decision-making based on technology deployment trends by utilities.

• Develop strategies for market penetration and product development

• Position yourself to gain the maximum advantage of the smart grid technology market’s growth potential

• Identify key partners and business development avenues

Huaneng Power International, Inc. - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 51
Price: $ 1000





The report Huaneng Power International, Inc. - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Energy Market Research

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
• Note*: Some sections may be missing if data is unavailable for the company.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Great Plains Energy Incorporated - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 56
Price: $ 1000





The report Great Plains Energy Incorporated - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Power Market

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Fingrid Oyj - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 35
Price: $ 1000





The report Fingrid Oyj - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Power Market Research Reports

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Guangzhou Development Industry (Holdings) Co., Ltd. - Power Plants and SWOT Analysis, 2011 Update

Published:  August 2011
No. of Pages: 24
Price: $ 1000





The report Guangzhou Development Industry (Holdings) Co., Ltd. - Power Plants and SWOT Analysis, 2011 Update contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Power Market

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Datang International Power Generation Company Limited - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011
No. of Pages: 56
Price: $ 1000




The report contains the profile of the company Datang International Power Generation Company Limited - Power Plants and SWOT Analysis, 2011 Update that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Power Market Research

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - GlobalData’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company Datang International Power Generation Company Limited.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Algonquin Power & Utilities Corp. - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011

No. of Pages: 50

Price: $ 1000

The report contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company's business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report Algonquin Power & Utilities Corp. - Power Plants and SWOT Analysis, 2011 Update contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Browse All: Energy Market Research

Scope 

* Major Power Plants (assets) - summarized and detailed information about the power plants (assets) 

* Operational Metrics (capacity, generation, revenue, sales, number of consumers) 

* Business description - A detailed description of the company's operations and business divisions 

* Corporate strategy - GlobalData's summarization of the company's business strategy. 

* SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats. 

* Company history - Progression of key events associated with the company Algonquin Power & Utilities Corp.. 

* Major products and services - A list of major products, services and brands * Key competitors - A list of key competitors. 

* Key employees - A list of the key executives 

* Executive biographies - A brief summary of the executives' employment history. 

* Key operational heads - A list of personnel heading key departments/functions. 

* Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy

* Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV). 

* Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy. 

* Understand and respond to competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

PT Medco Energi Internasional Tbk - Power Plants and SWOT Analysis, 2011 Update

Published: August 2011

No. of Pages: 50

Price: $ 1000

The report contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company’s business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report PT Medco Energi Internasional Tbk - Power Plants and SWOT Analysis, 2011 Update contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services. 

Browse all: Power Market Research Reports

Scope

• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)

• Operational Metrics (capacity, generation, revenue, sales, number of consumers)

• Business description - A detailed description of the company’s operations and business divisions

• Corporate strategy - GlobalData’s summarization of the company’s business strategy.

• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.

• Company history - Progression of key events associated with the company.

• Major products and services - A list of major products, services and brands

• Key competitors - A list of key competitors.

• Key employees - A list of the key executives

• Executive biographies - A brief summary of the executives’ employment history.

• Key operational heads - A list of personnel heading key departments/functions.

• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

• Note*: Some sections may be missing if data is unavailable for the company.

Reasons to buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).

• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

• Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

Gas Markets in Bangladesh, India, 2011

Bangladesh, India Gas Markets, 2011 - This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Bangladesh, India. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines, LNG terminals and underground gas storage facilities) in Bangladesh, India. The report India, Bangladesh Gas Markets, 2011 compares the investment environment in India with other countries in the region. The profiles of the major companies operating in the natural gas sector in India together with the latest news and deals are also included in the report.

Scope

• Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.

• Historical and forecast data and information for all the major gas fields, (Liquified Natural Gas) LNG Terminals, pipelines and underground gas storage facilities in India for the period 2000-2015.

• Operator and equity details for major natural gas assets in Bangladesh, India.

• Key information relating to market regulations, key energy assets and the key companies operating in the India's energy industry.

• Information on the top companies in the Bangladesh, India including business description, strategic analysis, and financial information.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

• Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy

• Gain a strong understanding of the country's energy market.

• Facilitate market analysis and forecasting of future industry trends.

• Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.

• Assess your competitor's major natural gas assets and their performance.

• Analyze the latest news and financial deals in the gas sector of each country.

• Develop strategies based on the latest operational, financial, and regulatory events.

• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.

• Identify and analyze the strengths and weaknesses of the leading companies in the country.

 

Oil Markets in Azerbaijan, Bangladesh, India, 2011

This profile is the essential source for top-level energy industry data and information. The report India, Bangladesh, Azerbaijan Oil Markets, 2011 provides an overview of each of the key sub-segments of the energy industry in Azerbaijan, Bangladesh, India. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in Azerbaijan, Bangladesh, India. The report compares the investment environment in Azerbaijan, Bangladesh, India with other countries in the region. The profiles of the major companies operating in the crude oil sector in Azerbaijan, Bangladesh, India together with the latest news and deals are also included in the report.

Scope

• Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.

• Historical and forecast data and information for all the major oil fields, refineries, pipelines and storage terminals in Azerbaijan, Bangladesh, India for the period 2000-2015.

• Operator and equity details for major crude oil assets in Azerbaijan, Bangladesh, India.

• Key information relating to market regulations, key energy assets and the key companies operating in the Azerbaijan, Bangladesh, India’s energy industry.

• Information on the top companies in the Azerbaijan, Bangladesh, India including business description, strategic analysis, and financial information.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

• Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy

• Gain a strong understanding of the country’s energy market.

• Facilitate market analysis and forecasting of future industry trends.

• Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.

• Assess your competitor’s major crude oil assets and their performance.

• Analyze the latest news and financial deals in the oil sector of Azerbaijan, India, Bangladesh Oil Markets, 2011.

• Develop strategies based on the latest operational, financial, and regulatory events.

• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.

• Identify and analyze the strengths and weaknesses of the leading companies in the country.